Michael Grant, MD, is an Assistant Professor of Medicine (Medical Oncology). Dr. Grant received his medical degree from the Albert Einstein School of Medicine and did his residency in Internal Medicine at Duke University School of Medicine. He completed his fellowship at Yale School of Medicine during which he was enrolled in the Yale Cancer Center T32 Advanced Training Program (YCC-ATPP) for Physician-Scientists which provides funding to fellows who are strongly committed to being independent physician-scientists performing basic, translational, clinical, or outcomes research in a cancer-related field. Dr. Grant cares for patients with lung cancer and other thoracic malignancies and his current research interests include targeted and immunotherapy approaches to the treatment of non-small cell lung cancer. In 2021, he received the ASCO Conquer Cancer Young Investigator Award to study sensitivity and resistance to EGFR-targeted therapies in patients with NSCLC harboring certain EGFR mutations.
